70岁及以上股骨颈骨折患者是否应使用双极半髋关节置换术?文献综述与随机对照试验的Meta分析
该系统综述与Meta分析纳入14项随机对照试验,比较双极半髋(BHA)与单极半髋(UHA)在老年移位股骨颈骨折患者中的效果。总体髋关节功能评分无差异(SMD 0.32,95%CI -0.06至0.71,n=1084,I²=87%),但随访超过2年的BHA患者髋功能评分更优(SMD 0.68,95%CI 0.18-1.18,n=700,I²=87%)。BHA可能降低髋臼侵蚀风险(RR 0.38,95%CI 0.17-0.83,n=1239,I²=0%),翻修、死亡率、感染和脱位无差异。
要点
- BHA与UHA总体髋功能评分无差异(SMD 0.32,95%CI -0.06至0.71,n=1084,I²=87%)。
- 随访超过2年时BHA髋功能评分更优(SMD 0.68,95%CI 0.18-1.18,n=700,I²=87%)。
- BHA降低髋臼侵蚀风险(RR 0.38,95%CI 0.17-0.83,n=1239,I²=0%),翻修、死亡率、感染、脱位无差异。
核心结论
- BHA与UHA在2年时髋关节功能似乎无差异。
- BHA可能降低髋臼侵蚀风险。
- 需要一项随访超过2年、采用更好测量工具的大型随机对照试验来评估临床获益。
研究设计与样本
- 系统综述与Meta分析,比较BHA与UHA的随机对照试验,共纳入14项随机对照试验。
- 数据来源为MEDLINE、EMBASE、Cochrane Library和Web of Science,最后检索日期为2020年6月1日。
- 主要结局为术后髋关节功能评分;次要结局为整体健康相关生活质量患者报告结局、髋臼侵蚀和术后并发症。
主要发现
- BHA与UHA的髋功能评分无差异(SMD 0.32,95%CI -0.06至0.71,n=1084,I²=87%)。
- 随访超过2年的BHA患者髋功能评分更优(SMD 0.68,95%CI 0.18-1.18,n=700,I²=87%)。
- BHA的欧洲五维健康量表评分无差异(MD 0.08,95%CI -0.01至0.17,n=967,I²=82%)。
- BHA降低髋臼侵蚀风险(RR 0.38,95%CI 0.17-0.83,n=1239,I²=0%)。
- 翻修、死亡率、感染和脱位无差异(I²=0%)。
关键数值与推荐
- 髋功能评分:BHA vs UHA的SMD 0.32(95%CI -0.06至0.71,n=1084,I²=87%)。
- 随访超过2年的髋功能评分:BHA vs UHA的SMD 0.68(95%CI 0.18-1.18,n=700,I²=87%)。
- 欧洲五维健康量表评分:BHA vs UHA的MD 0.08(95%CI -0.01至0.17,n=967,I²=82%)。
- 髋臼侵蚀:BHA vs UHA的RR 0.38(95%CI 0.17-0.83,n=1239,I²=0%)。
- 翻修、死亡率、感染和脱位:BHA vs UHA无差异(I²=0%)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 需要一项随访超过2年、采用更好测量工具的大型随机对照试验来评估临床获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Bipolar (BHA) and unipolar hemiarthroplasties (UHA) are interchangeably used in elderly patients with a displaced femoral neck fracture. We ask if there is a difference between BHA and UHA with regards to hip function, in elderly patients. METHODS: Systematic review and meta-analysis was conducted of randomized controlled trials comparing BHA to UHA. The primary outcome was postoperative hip function scores. Secondary outcomes were overall health-related quality of life patient-reported outcomes, acetabular erosion, and postoperative complications. Data sources, last searched on June 1, 2020, were MEDLINE, EMBASE, Cochrane Library, and Web of Science. RESULTS: Fourteen randomized controlled trials were eligible for meta-analysis. There was no difference in hip function scores between BHA and UHA (standardized mean difference 0.32, 95% confidence interval [CI] -0.06 to 0.71, n = 1084, I2 = 87%). Patients with BHA with more than 2-year follow-up had better hip function scores (standardized mean difference 0.68, 95% CI 0.18-1.18, n = 700, I2 = 87%). There was no difference in European Quality of life- five dimensions scores with BHA (mean difference 0.08, 95% CI -0.01 to 0.17, n = 967, I2 = 82%). The use of BHA decreased the risk of acetabular erosion (relative risk 0.38, 95% CI 0.17-0.83, n = 1239, I2 = 0%). There was no difference for revision, mortality, infection, and dislocation (I2 = 0%). CONCLUSION: There seems to be no difference between BHA and UHA with regards to hip function at 2 years. BHA might decrease the risk of acetabular erosion. There is a need for a large randomized controlled trial with a follow-up >2 years and better measurement tools to assess clinical benefits. LEVEL OF EVIDENCE: II.
引用
- Beauchamp-Chalifour P, Pelet S, Belhumeur V, et al. Should We Use Bipolar Hemiarthroplasty in Patients ≥70 Years Old With a Femoral Neck Fracture? A Review of Literature and Meta-Analysis of Randomized Controlled Trials. J Arthroplasty. 2021. PMID: 34915132. doi:10.1016/j.arth.2021.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。